RE: [NMusers] Modeling of two time-to-event outcomes

2009-07-22 Thread Stephen Duffull
Anthony We've been working with extreme value Copula functions for conjoining survival analyses in MATLAB. I wasn't sure, however, whether these could be implemented easily in NONMEM. Steve -Original Message- From: A.J. Rossini [mailto:blindgl...@gmail.com] Sent: Wednesday, 22

Re: [NMusers] Modeling of two time-to-event outcomes

2009-07-22 Thread Nick Holford
Steve, I've been hearing about copulas for a couple of years now but haven't seen anything which reveals how they can be translated into the real world. If we take the example I gave of hospitalization for heart disease and death as being two 'correlated' events. Is there something like a

Re: [NMusers] Modeling of two time-to-event outcomes

2009-07-22 Thread A.J. Rossini
Nick - The point of copulas is to write a pair of survival (or distribution) functions in a way that you can add parameters to link them together to describe the correlation structure. It's reasonably flexible. Check out the stats literature, it's quite common, even in the applied journals.

[NMusers] Dynamic enzymatic model

2009-07-22 Thread christian woloch
Dear all, I try to model simultaneously a parent drug and its metabolite using a 2 compartments dynamic enzymatic model (using the general enzymatic reaction E+S--(ES)--E+P). Here is the control stream : $PROB TEST MODELISATION NLIN 2CPMT $INPUT ID TIME DV AMT MDV CMT $DATA DATA131.csv IGNORE=#

RE: [NMusers] Dynamic enzymatic model

2009-07-22 Thread Gibiansky, Ekaterina
Christian, Is this infusion or oral dosing? If infusion, you need RATE data item, if oral, you need absorption compartment. Also, there is a problem with volumes. If A(1 ) and A(2) are amounts and A(3) is concentration of the complex, you need to multiply KE2 * A(3) by V3 in equation 2. And

Re: [NMusers] Dynamic enzymatic model

2009-07-22 Thread saik.urien.svp
Christian There is at least one parameter you cannot estimate in this code, this is V2 (volume of distribution of the metabolite) This parameter is not identifiable because the fraction of parent drug that is metabolized is unknown and the volume of distribution simply relates the